NEW YORK (GenomeWeb) — Premaitha Health reported a 24 percent revenue increase for its fiscal year 2016/2017 today.

For the year ended March 31, the Manchester, UK-based molecular diagnostics company, which focuses on noninvasive prenatal testing, had more than £3.1 million ($4 million) in revenue, up from £2.5 million during the previous fiscal year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.